Better Than Ozempic? Retatrutide Delivers Double Ozempic's Weight Loss In Phase 3 Trial
Could a new generation of weight-loss medicines deliver substantially greater results for people living with type 2 diabetes? New Phase 3 trial findings from pharmaceutical…
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 29 03:39 ETSource: NDTV
From the source
Read at ndtv.comBetter Than Ozempic? Retatrutide Delivers Double Ozempic's Weight Loss In Phase 3 Trial
Could a new generation of weight-loss medicines deliver substantially greater results for people living with type 2 diabetes? New Phase 3 trial findings from pharmaceutical company Eli Lilly suggest that retatrutide, an experimental drug, may offer a significant improvement in weight reduction compared with semaglutide, the active ingredient in Ozempic.
